Lung ultrasound (LUS) has recently become a frequently used diagnostic tool in everyday pediatric clinical practice among both clinicians and radiologists. LUS has good diagnostic accuracy for several neonatal diseases (congenital and acquired) and is useful to guide treatment (i.e. surfactant for respiratory distress syndrome, pleural drainage for pneumothorax and pleural effusions), to enable a faster diagnosis of potentially critical diseases (i.e. pneumothorax), to predict bronchopulmonary dysplasia and monitor the evolution of some conditions over time (i.e. bronchopulmonary dysplasia, pneumonia). Another benefit of LUS implementation in clinical practice is a significant reduction (by 20-30%) of radiation exposure which is particularly significant for this vulnerable population. Dynamic monitoring of changes in neonatal pulmonary conditions is one of the major advantages of LUS, which is helpful for decision-making. New applications of LUS include the use of contrast-enhanced ultrasound in complicated pneumonia and the evaluation of lung recruitment and endotracheal tube placement.
The goal of this Research Topic is to critically promote the use of LUS in the neonatal population, to address the current controversies of its application, to establish uniform diagnostic protocols and criteria for congenital and acquired lung diseases, and to emphasize all the benefits, potentials, as well as limitations and disadvantages of LUS in comparison with other diagnostic modalities (chest X-rays and computed tomography).
We welcome submissions of Original Research articles, Reviews, and high-quality and hypothesis-generating Case Reports on the application of ultrasound in the diagnosis, treatment, and care of neonatal and pediatric lung diseases.
Topics of interest include but are not limited to, the following aspects.
1. Novel findings of LUS in the diagnosis, approach, and treatment of lung disease, especially the related multi-center prospective studies.
2. Role of LUS in guiding neonatal and pediatric mechanical ventilation.
3. Role of LUS in optimizing the administration of surfactant therapy and the provision of invasive and non-invasive ventilation.
Lung ultrasound (LUS) has recently become a frequently used diagnostic tool in everyday pediatric clinical practice among both clinicians and radiologists. LUS has good diagnostic accuracy for several neonatal diseases (congenital and acquired) and is useful to guide treatment (i.e. surfactant for respiratory distress syndrome, pleural drainage for pneumothorax and pleural effusions), to enable a faster diagnosis of potentially critical diseases (i.e. pneumothorax), to predict bronchopulmonary dysplasia and monitor the evolution of some conditions over time (i.e. bronchopulmonary dysplasia, pneumonia). Another benefit of LUS implementation in clinical practice is a significant reduction (by 20-30%) of radiation exposure which is particularly significant for this vulnerable population. Dynamic monitoring of changes in neonatal pulmonary conditions is one of the major advantages of LUS, which is helpful for decision-making. New applications of LUS include the use of contrast-enhanced ultrasound in complicated pneumonia and the evaluation of lung recruitment and endotracheal tube placement.
The goal of this Research Topic is to critically promote the use of LUS in the neonatal population, to address the current controversies of its application, to establish uniform diagnostic protocols and criteria for congenital and acquired lung diseases, and to emphasize all the benefits, potentials, as well as limitations and disadvantages of LUS in comparison with other diagnostic modalities (chest X-rays and computed tomography).
We welcome submissions of Original Research articles, Reviews, and high-quality and hypothesis-generating Case Reports on the application of ultrasound in the diagnosis, treatment, and care of neonatal and pediatric lung diseases.
Topics of interest include but are not limited to, the following aspects.
1. Novel findings of LUS in the diagnosis, approach, and treatment of lung disease, especially the related multi-center prospective studies.
2. Role of LUS in guiding neonatal and pediatric mechanical ventilation.
3. Role of LUS in optimizing the administration of surfactant therapy and the provision of invasive and non-invasive ventilation.
